Where is the locus in opioid withdrawal?

By Christie M.J.   Williams J.T.   Osborne P.B.   Bellchambers C.E.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 4, 1997-04 ,pp. : 134-140

Elsevier

Access to resources Recommend Favorite

Modulation of glutamate release by a -opioid receptor agonist in rodent and primate striatum

By Hill M.P.   Brotchie J.M.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Possible involvement of the locus coeruleus in inhibition by prostanoid EP 3 receptor-selective agonists of morphine withdrawal syndrome in rats

By Nakagawa T.   Masuda T.   Watanabe T.   Minami M.   Satoh M.  

European Journal of Pharmacology, Vol. 390, Iss. 3, 2000-03 ,pp. : 257-266

Elsevier

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T.   Aoki T.   Ohnishi O.   Nagase H.   Narita M.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite

Tachykinin NK 1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus

By Hahn M.K.   Bannon M.J.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite